Have a feature idea you'd love to see implemented?
Let us know!
ZOM Zomedica Corp
Price (delayed)
$0.1303
Market cap
$127.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.06
Enterprise value
$122.04M
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will
Highlights
The revenue is up by 16% year-on-year
Zomedica's gross profit has increased by 15% YoY
The debt has soared by 61% YoY but it has decreased by 8% from the previous quarter
The company's EPS has shrunk by 200% YoY and by 50% QoQ
ZOM's net income has dropped by 176% year-on-year and by 51% since the previous quarter
Key stats
What are the main financial stats of ZOM
Market
Valuations
Earnings
Shares outstanding
979.95M
Market cap
$127.69M
Enterprise value
$122.04M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.61
Price to sales (P/S)
4.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.68
Revenue
$26.08M
EBIT
-$57.15M
EBITDA
-$55.97M
Free cash flow
-$34.42M
Per share
Balance sheet
Liquidity
EPS
-$0.06
Free cash flow per share
-$0.04
Book value per share
$0.21
Revenue per share
$0.03
TBVPS
$0.12
Total assets
$219.88M
Total liabilities
$11.16M
Debt
$2.29M
Equity
$208.72M
Working capital
$81.39M
Debt to equity
0.01
Current ratio
11.39
Quick ratio
10.42
Net debt/EBITDA
0.1
Margins
Efficiency
Dividend
EBITDA margin
-214.6%
Gross margin
68.7%
Net margin
-212.6%
Operating margin
-247.3%
Return on assets
-22.4%
Return on equity
-23.6%
Return on invested capital
-50.5%
Return on capital employed
-27%
Return on sales
-219.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZOM stock price
How has the Zomedica stock price performed over time
Intraday
-0.46%
1 week
-0.08%
1 month
1.88%
1 year
-23.08%
YTD
-34.92%
QTD
-5.03%
Financial performance
How have Zomedica's revenue and profit performed over time
Revenue
$26.08M
Gross profit
$17.91M
Operating income
-$64.49M
Net income
-$55.44M
Gross margin
68.7%
Net margin
-212.6%
ZOM's net income has dropped by 176% year-on-year and by 51% since the previous quarter
The operating income has plunged by 148% YoY and by 40% from the previous quarter
The net margin has plunged by 138% YoY and by 50% from the previous quarter
Zomedica's operating margin has plunged by 114% YoY and by 39% from the previous quarter
Growth
What is Zomedica's growth rate over time
Valuation
What is Zomedica stock price valuation
P/E
N/A
P/B
0.61
P/S
4.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.68
The company's EPS has shrunk by 200% YoY and by 50% QoQ
ZOM's P/B is 78% below its 5-year quarterly average of 2.8 and 13% below its last 4 quarters average of 0.7
The equity fell by 20% YoY and by 10% QoQ
The P/S is 23% below the last 4 quarters average of 6.4
The revenue is up by 16% year-on-year
Efficiency
How efficient is Zomedica business performance
The company's return on sales has shrunk by 129% YoY and by 48% QoQ
Zomedica's ROA has plunged by 60% from the previous quarter
ZOM's return on equity has dropped by 59% since the previous quarter
The ROIC has plunged by 56% from the previous quarter
Dividends
What is ZOM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ZOM.
Financial health
How did Zomedica financials performed over time
Zomedica's quick ratio has decreased by 43% YoY and by 2.3% QoQ
ZOM's current ratio is down by 41% year-on-year
The debt is 99% less than the equity
The debt has soared by 61% YoY but it has decreased by 8% from the previous quarter
The equity fell by 20% YoY and by 10% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.